ARDELYX INC. - COMMON STOCK

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

08 янв 2024 08:45:43 Источник NetDania Notify

Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities

08 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8

03 янв 2024 07:03:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

20 дек 2023 08:45:03 Источник NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

20 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

19 дек 2023 08:46:12 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

18 дек 2023 08:45:08 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

15 дек 2023 08:45:15 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

14 дек 2023 08:45:03 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

13 дек 2023 08:47:25 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

07 дек 2023 08:45:06 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

06 дек 2023 11:28:31 Источник NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

21 ноя 2023 15:02:00 Источник Nasdaq GlobeNewswire

Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference

21 ноя 2023 07:01:45 Источник Nasdaq GlobeNewswire

XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia

15 ноя 2023 15:02:00 Источник Nasdaq GlobeNewswire

Ardelyx Announces Departure of Board Member

13 ноя 2023 15:02:00 Источник Nasdaq GlobeNewswire

Ardelyx to Participate at the Jefferies London Healthcare Conference

10 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

06 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance

31 окт 2023 06:00:01 Источник Nasdaq GlobeNewswire